Outcomes in Minimally Invasive Versus Open Pancreaticoduodenectomy
A Pilot Study Evaluating Health-related Quality of Life Endpoints in Patients Undergoing Minimally Invasive Versus Open Pancreaticoduodenectomy
Sponsor: Duke University
This observational or N/A phase trial investigates Pancreatic Disease and is currently completed. Duke University leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Mar 2020 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Oct 2019 — Mar 2020 [monthly]
Active Not Recruiting
Status: Enrolling By Invitation → Active Not Recruiting
▶ Show 5 earlier versions
-
Jun 2019 — Oct 2019 [monthly]
Enrolling By Invitation
-
Nov 2018 — Jun 2019 [monthly]
Enrolling By Invitation
-
Jun 2018 — Nov 2018 [monthly]
Enrolling By Invitation
-
Apr 2018 — Jun 2018 [monthly]
Enrolling By Invitation
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Enrolling By Invitation NA
First recorded
Jul 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Duke University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.